Your browser doesn't support javascript.
loading
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19.
Peluso, Michael J; Ryder, Dylan; Flavell, Robert; Wang, Yingbing; Levi, Jelena; LaFranchi, Brian H; Deveau, Tyler-Marie; Buck, Amanda M; Munter, Sadie E; Asare, Kofi A; Aslam, Maya; Koch, Wally; Szabo, Gyula; Hoh, Rebecca; Deswal, Monika; Rodriguez, Antonio; Buitrago, Melissa; Tai, Viva; Shrestha, Uttam; Lu, Scott; Goldberg, Sarah A; Dalhuisen, Thomas; Durstenfeld, Matthew S; Hsue, Priscilla Y; Kelly, J Daniel; Kumar, Nitasha; Martin, Jeffrey N; Gambir, Aruna; Somsouk, Ma; Seo, Youngho; Deeks, Steven G; Laszik, Zoltan G; VanBrocklin, Henry F; Henrich, Timothy J.
Afiliação
  • Peluso MJ; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA USA.
  • Ryder D; Division of Experimental Medicine, University of California San Francisco.
  • Flavell R; Department of Radiology and Biomedical Imaging, University of California San Francisco.
  • Wang Y; Department of Radiology and Biomedical Imaging, University of California San Francisco.
  • Levi J; CellSight Technologies, San Francisco, CA.
  • LaFranchi BH; Division of Experimental Medicine, University of California San Francisco.
  • Deveau TM; Division of Experimental Medicine, University of California San Francisco.
  • Buck AM; Division of Experimental Medicine, University of California San Francisco.
  • Munter SE; Division of Experimental Medicine, University of California San Francisco.
  • Asare KA; Division of Experimental Medicine, University of California San Francisco.
  • Aslam M; Department of Radiology and Biomedical Imaging, University of California San Francisco.
  • Koch W; Department of Radiology and Biomedical Imaging, University of California San Francisco.
  • Szabo G; Department of Pathology, University of California San Francisco.
  • Hoh R; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA USA.
  • Deswal M; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA USA.
  • Rodriguez A; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA USA.
  • Buitrago M; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA USA.
  • Tai V; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA USA.
  • Shrestha U; Department of Radiology and Biomedical Imaging, University of California San Francisco.
  • Lu S; Department of Epidemiology and Biostatistics, University of California San Francisco.
  • Goldberg SA; Department of Epidemiology and Biostatistics, University of California San Francisco.
  • Dalhuisen T; Department of Epidemiology and Biostatistics, University of California San Francisco.
  • Durstenfeld MS; Division of Cardiology, University of California San Francisco.
  • Hsue PY; Division of Cardiology, University of California San Francisco.
  • Kelly JD; Department of Epidemiology and Biostatistics, University of California San Francisco.
  • Kumar N; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA USA.
  • Martin JN; Department of Epidemiology and Biostatistics, University of California San Francisco.
  • Gambir A; CellSight Technologies, San Francisco, CA.
  • Somsouk M; Division of Gastroenterology, University of California San Francisco.
  • Seo Y; Department of Radiology and Biomedical Imaging, University of California San Francisco.
  • Deeks SG; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA USA.
  • Laszik ZG; Department of Pathology, University of California San Francisco.
  • VanBrocklin HF; Department of Radiology and Biomedical Imaging, University of California San Francisco.
  • Henrich TJ; Division of Experimental Medicine, University of California San Francisco.
medRxiv ; 2023 Jul 31.
Article em En | MEDLINE | ID: mdl-37577714
The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. We performed whole-body positron emission tomography (PET) imaging in a cohort of 24 participants at time points ranging from 27 to 910 days following acute SARS-CoV-2 infection using a novel radiopharmaceutical agent, [18F]F-AraG, a highly selective tracer that allows for anatomical quantitation of activated T lymphocytes. Tracer uptake in the post-acute COVID group, which included those with and without Long COVID symptoms, was significantly higher compared to pre-pandemic controls in many anatomical regions, including the brain stem, spinal cord, bone marrow, nasopharyngeal and hilar lymphoid tissue, cardiopulmonary tissues, and gut wall. Although T cell activation tended to be higher in participants imaged closer to the time of the acute illness, tracer uptake was increased in participants imaged up to 2.5 years following SARS-CoV-2 infection. We observed that T cell activation in spinal cord and gut wall was associated with the presence of Long COVID symptoms. In addition, tracer uptake in lung tissue was higher in those with persistent pulmonary symptoms. Notably, increased T cell activation in these tissues was also observed in many individuals without Long COVID. Given the high [18F]F-AraG uptake detected in the gut, we obtained colorectal tissue for in situ hybridization SARS-CoV-2 RNA and immunohistochemical studies in a subset of participants with Long COVID symptoms. We identified cellular SARS-CoV-2 RNA in rectosigmoid lamina propria tissue in all these participants, ranging from 158 to 676 days following initial COVID-19 illness, suggesting that tissue viral persistence could be associated with long-term immunological perturbations.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos